Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Muscular dystrophies with reduced glycosylation of alpha-dystroglycan (alpha-DG), commonly referred to as dystroglycanopathies, are a heterogeneous group of autosomal recessive conditions which include a wide spectrum of clinical severity. Reported phenotypes range from severe congenital onset Walker-Warburg syndrome (WWS) with severe structural brain and eye involvement, to relatively mild adult onset limb girdle muscular dystrophy (LGMD). Specific clinical syndromes were originally described in association with mutations in any one of six demonstrated or putative glycosyltransferases. Work performed on patients with mutations in the FKRP gene has identified that the spectrum of phenotypes due to mutations in this gene is much wider than originally assumed. To further define the mutation frequency and phenotypes associated with mutations in the other five genes, we studied a large cohort of patients with evidence of a dystroglycanopathy. Exclusion of mutations in FKRP was a prerequisite for participation in this study. Ninety-two probands were screened for mutations in POMT1, POMT2, POMGnT1, fukutin and LARGE. Homozygous and compound heterozygous mutations were detected in a total of 31 probands (34 individuals from 31 families); 37 different mutations were identified, of which 32 were novel. Mutations in POMT2 were the most prevalent in our cohort with nine cases, followed by POMT1 with eight cases, POMGnT1 with seven cases, fukutin with six cases and LARGE with only a single case. All patients with POMT1 and POMT2 mutations had evidence of either structural or functional central nervous system involvement including four patients with mental retardation and a LGMD phenotype. In contrast mutations in fukutin and POMGnT1 were detected in four patients with LGMD and no evidence of brain involvement. The majority of patients (six out of nine) with mutations in POMT2 had a Muscle-Eye-Brain (MEB)-like condition. In addition we identified a mutation in the gene LARGE in a patient with WWS. Our data expands the clinical phenotypes associated with POMT1, POMT2, POMGnT1, fukutin and LARGE mutations. Mutations in these five glycosyltransferase genes were detected in 34% of patients indicating that, after the exclusion of FKRP, the majority of patients with a dystroglycanopathy harbour mutations in novel genes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A child affected with ASD and moderate intellectual disability was found to have a homozygous missense change (p.R367H) in POMGNT1 (Table 1B; Figure S4). POMGNT1 is responsible for an inherited dystroglycanopathy characterized by brain malformation, intellectual disability, developmental delay, hypotonia, and myopia; interestingly, rare patients have been reported with severe autistic features (”
From Using Whole-Exome Sequencing to Identify Inherited Causes of Autism (2013) · cites this paper as Godfrey et al., 2007
Citations
Cites
Muscle Biopsy: A Practical Approach
Dubowitz, V., Sewry, C. A., Oldfors, A., & Lane, R. J. M. (2020) · Cited by 1,335
Self-citationAn ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
Kobayashi, K., Nakahori, Y., Miyake, M., Matsumura, K., Kondo-Iida, E., Nomura, Y., Segawa, M., Yoshioka, M., Saito, K., Osawa, M., et al. (1998) · Nature · doi:10.1038/28653 · Cited by 802
Yoshida, A., Kobayashi, K., Manya, H., Taniguchi, K., Kano, H., Mizuno, M., Inazu, T., Mitsuhashi, H., Takahashi, S., Takeuchi, M., et al. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00070-3 · Cited by 706 · cited 2×
“These genes are thought to be involved in the addition of carbohydrate residues onto the -DG backbone either via the process of O-mannosylation (POMT1, POMT2, POMGnT1) (Yoshida et al., 2001; Manya et al., 2003; Akasaka-Manya et al., 2004) or via other not fully characterized mechanisms (fukutin, FKRP and LARGE) (de Pa…”
BackgroundSelf-citationBeltrán-Valero de Bernabé, D., Currier, S., Steinbrecher, A., Celli, J., van Beusekom, E., van der Zwaag, B., Kayserili, H., Merlini, L., Chitayat, D., Dobyns, W. B., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342975 · Cited by 685
Brockington, M., Blake, D. J., Prandini, P., Brown, S. C., Torelli, S., Benson, M. A., Ponting, C. P., Estournet, B., Romero, N. B., Mercuri, E., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/324412 · Cited by 603
Self-citationDystroglycan: from biosynthesis to pathogenesis of human disease
Barresi, R., & Campbell, K. P. (2006) · Journal of Cell Science · doi:10.1242/jcs.02814 · Cited by 596
Williamson, R. A., Henry, M. D., Daniels, K. J., Hrstka, R. F., Lee, J. C., Sunada, Y., Ibraghimov-Beskrovnaya, O., & Campbell, K. P. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.6.831 · Cited by 541
Brockington, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.25.2851 · Cited by 499
Self-citationLongman, C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg307 · Cited by 416
Self-citationPOMT2 mutations cause α-dystroglycan hypoglycosylation and Walker-Warburg syndrome
van Reeuwijk, J., Janssen, M., van den Elzen, C., Beltran-Valero de Bernabé, D., Sabatelli, P., Merlini, L., Boon, M., Scheffer, H., Brockington, M., Muntoni, F., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.031963 · Cited by 414
Self-citation
Cited by
Items 401–465 of 465
Uribe, M. L. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Geis, T., Hehr, U., Brandl, R., Herbst, S. M., Segerer, H., Melter, M., & Hinreiner, S. (2018) · OBM Genetics · doi:10.21926/obm.genet.1801015
Expresión de genes y proteínas asociados a distroglicanopatías en fotorreceptores en cultivo
Haro, C. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Fukutin and Fukutin-Related Protein (FKRP)
Kanagawa, M., & Toda, T. (2014) · Springer eBooks · doi:10.1007/978-4-431-54240-7_141
Caracterização citogénica e genómica de pacientes com MAC (microftalmia, anoftalmia e coloboma)
Estrela, F. J. S. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Fukuyama Congenital Muscular Dystrophy and Related Diseases
Kanagawa, M., Tokuoka, H., & Toda, T. (2019) · Springer eBooks · doi:10.1007/978-981-13-2977-7_20
Conformational Regulation of Cell Surface Receptor Proteolysis
Hayward, A. N. (2019) · University of Minnesota Digital Conservancy (University of Minnesota)
Клинико-генетическая характеристика наследственных заболеваний и синдромов с глаукомой
Хлебникова, О. В., & Леонидовна, Д. Е. (2017) · Nauchno-prakticheskii zhurnal «Medicinskaia genetika»
Congenital muscular dystrophy a case study with a mutation in the POMT1 gene
Elmas, M., Göğüş, B., Cavusoglu, D., Pektas, A., & Solak, M. (2019) · Journal of Biochemical and Clinical Genetics · doi:10.24911/jbcgenetics/183-1566823566
Xu, L. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Clinical and genetic characteristics of congenital muscular dystrophies (part 2)
Chausova, P. A., Рыжкова, О. П., & Polyakov, A. V. (2020) · Neuromuscular Diseases · doi:10.17650/2222-8721-2020-10-2-12-21
Neuroimaging and Genetics in Brain Maldevelopment
Pooh, R. K. (2020) · Comprehensive gynecology and obstetrics · doi:10.1007/978-981-15-8171-7_7
α-Dystroglycanopathy: Molecular Mechanism, Clinical Manifestations, and Therapeutic Approaches
Nagasaka, M., & Taniguchi‐Ikeda, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00067-5
Distrofias musculares congénitas en el niño
Mauro, C. S., & Acevedo, G. B. (2013) · Revista de Neurología · doi:10.33588/rn.57s01.2013240
Holman, N. (2019) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Limb-Girdle Muscular Dystrophy Type 2N
Angelini, C. I. (2014) · Springer eBooks · doi:10.1007/978-3-319-07500-6_17
Glycans and Muscular Dystrophy
Endo, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00003-1
(2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32830fb782
Yoshioka, M. (2012) · InTech eBooks · doi:10.5772/30327
Congenital muscular dystrophies
Havlín, O., Bálintová, Z., Juříková, L., & Ošlejšková, H. (2022) · Neurologie pro praxi · doi:10.36290/neu.2021.070
Jones, J. C. R., & Hopkinson, S. B. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.9282960.12576054
Bharucha-Goebel, D. X., & Bönnemann, C. G. (2014) · Springer eBooks · doi:10.1007/978-1-4614-8515-5_36
Thomas, J. A., Greene, C. L., & Berry, G. T. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0134-0.10023-x
Gao, Y., Kang, Z., Wei, X., Miao, J., & Yu, X. (2019) · Research Square · doi:10.21203/rs.2.483/v1
Muscular Dystrophies and Allied Disorders III
(2020) · Elsevier eBooks · doi:10.1016/b978-0-7020-7471-4.00012-4
福山型筋ジストロフィーとその類縁疾患における病態 糖鎖における生体調節とその破綻
Tamao, E. N. D. O. (2009) · KAGAKU TO SEIBUTSU · doi:10.1271/kagakutoseibutsu.47.244
Yamamoto, T., Okamura, Y., Tsukui, R., Kato, Y., Onizuka, H., & Masui, K. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.108063
Potential Therapeutic Strategies for Muscular Dystrophy
Gaina, G. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102255
eLife Assessment: Inhibitory CCK+ basket synapse defects in mouse models of dystroglycanopathy
Overstreet‐Wadiche, L. (2023) · eLife · doi:10.7554/elife.87965.1.sa3
eLife Assessment: Inhibitory CCK+ basket synapse defects in mouse models of dystroglycanopathy
Overstreet‐Wadiche, L. (2023) · eLife · doi:10.7554/elife.87965.2.sa3
Astejada, M., & Nishino, I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00185-x
Muscle weakness (genetic muscle diseases)
Lin, A. Y., & Wang, L. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99417-0.00017-3
Congenital, Limb-Girdle, and Other Muscular Dystrophies
McAnally, M., Mohassel, P., & Bönnemann, C. G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00168-2
Carrier, I., Diez, E., Piscopo, V. E. C., Bechstedt, S., van Bokhoven, H., Srour, M., Berghuis, A. M., Stifani, S., Yamanaka, Y., & McInnes, R. R. (2025) · eLife · doi:10.7554/elife.107102.1
Die molekulare Analyse von Muskelspindeln in der DMDmdx-Maus
Limbeck, S. M. (2021) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.27913
Miller, D. S., & Wright, K. M. (2021) · Figshare · doi:10.6084/m9.figshare.15128189
Miller, D. S., & Wright, K. M. (2021) · Figshare · doi:10.6084/m9.figshare.15128186
Miller, D. S., & Wright, K. M. (2021) · Figshare · doi:10.6084/m9.figshare.15128183
Characterization and therapy of congenital disorders of glycosylation
Häuptle, M. A. (2009) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-25761
Miller, D. S., & Wright, K. M. (2021) · Figshare · doi:10.6084/m9.figshare.15128177
Miller, D. S., & Wright, K. M. (2021) · Figshare · doi:10.6084/m9.figshare.15128180
Glyc-O-genetics of Walker-Warburg syndrome.
Reeuwijk, J. V. (2008) · Radboud Repository (Radboud University)
Astrea, G. (2013) · Electronic Theses and Dissertations Repository (University of Pisa)
Stahn, J. (. (2013) · URN:NBN Resolver for Germany & Switzerland (German National Library)
Buchignani, B. (2022) · Electronic Theses and Dissertations Repository (University of Pisa)
Therapeutic Development for Dystroglycanopathy Caused by Glycosylation Defects
Tokuoka, H., & Kanagawa, M. (2025) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.2518.1e
Therapeutic Development for Dystroglycanopathy Caused by Glycosylation Defects
Tokuoka, H., & Kanagawa, M. (2025) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.2518.1j
La modularité de la dysferline peut-elle permettre le développement d'approches thérapeutiques?
Barthélémy, F. (2013) · theses.fr (ABES) · doi:10.70675/b51efb0fz3b2ez406dz8b41za40ff9115334
Autosomal Dominant Missense DAG1 Variant Linked to Mild–Moderate LGMD R16
Malfatti, E., Caramizaru, A., Trentin, F., Dumitrescu, A., Sali, L., Bastian, A., Lee, H., Tajsharghi, H., Verebi, C., Nectoux, J., et al. (2026) · Human Mutation · doi:10.1155/humu/7451586
Self-citationCarrier, I., Diez, E., Piscopo, V. E. C., Bechstedt, S., van Bokhoven, H., Srour, M., Berghuis, A. M., Stifani, S., Yamanaka, Y., & McInnes, R. (2026) · eLife · doi:10.7554/elife.107102.3.sa3
Koyano, Y., Miura‐Fuchino, R., Kono, T., Hoshino, Y., Iwabuchi, E., & Kajikawa, D. (2026) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.70247
Complexity of matriglycan and dystroglycan expression in cancers of epithelium origin
Blaeser, A., Branch, E. K., Holbrook, M. C., & Lu, Q. (2026) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2026.100203
Expanding the Genotypic Spectrum of POMGNT1‐Related Muscle‐Eye‐Brain Disease: A Case Report
Pityrigkas, E., Poulidou, V., Kalampokini, S., Liouta, E., Pepe, G., Spilioti, M., & Kimiskidis, V. Κ. (2026) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.70256
A rhesus macaque model of α‐dystroglycanopathy caused by a POMT1 splice altering variant
Nordlund, A., LaMendola, B., Crilly, N. P., Kittle, S., Ferguson, B. M., Lewis, A. D., Wall, J., & Peterson, S. M. (2026) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70277
Summers, C., Dauletbayeva, S., Novikov, B., Nguyen, I., Manzini, M. C., & Panin, V. M. (2026) · Glycobiology · doi:10.1093/glycob/cwag071
Song, D., Liu, Y., Lin, S., Luo, J., Fu, X., 杨海坡, Zhu, Y., & Xiong, H. (2026) · Research Square · doi:10.21203/rs.3.rs-11320201/v1
Genetic and biochemical insights into muscular dystrophy-dystroglycanopathy pathomechanisms
Riemersma, M. (2015) · Radboud Repository (Radboud University)
DNAJB6 mutated LGMD1D - The clinical phenotype
Sandell, S. (2015) · Tampere University Institutional Repository (Tampere University)
Metadata
- Authors
- Godfrey, C., Clement, E., Mein, R., Brockington, M., Smith, J., Talim, B., Straub, V., Robb, S., Quinlivan, R., Feng, L., Jimenez-Mallebrera, C., Mercuri, E., Manzur, A. Y., Kinali, M., Torelli, S., Brown, S. C., Sewry, C. A., Bushby, K., Topaloglu, H., North, K., Abbs, S., & Muntoni, F.
- Affiliations
- The University of Sydney (AU)
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-10-01
- Volume
- 130
- Issue
- 10
- Pages
- 2725-2735
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2128173275
- Cited by
- 441
- References
- 35
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 13 · 2023: 21 · 2022: 13 · 2021: 24 · 2020: 23 · 2019: 21 · 2018: 23 · 2017: 21 · 2016: 22 · 2015: 24 · 2014: 33 · 2013: 34 · 2012: 35
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- dystroglycanopathies, alpha-dystroglycan glycosylation, genotype-phenotype correlation, POMT1, POMT2, POMGnT1, fukutin, LARGE, limb-girdle muscular dystrophy, Walker-Warburg syndrome, compound heterozygosity
- MeSH terms
- Child, Preschool, DNA Mutational Analysis, Glycosylation, Humans, Infant, Male, Mannosyltransferases, Membrane Proteins, Muscular Dystrophies, Mutation, Phenotype, Cohort Studies, N-Acetylglucosaminyltransferases, Dystroglycans, Muscular Dystrophies, Limb-Girdle
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.